biospecimen__admin__batch_number	365.54.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	100D71F7-A640-43CC-8F60-D3B387F8553C
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-A7M7-01A-12R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-A7M7-01A-01
biospecimen__bio__bcr_sample_barcode	TCGA-G3-A7M7-01A
biospecimen__bio__biospecimen_barcode_bottom	0160339138
biospecimen__bio__day_of_creation	25
biospecimen__bio__day_of_shipment	18
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	09
biospecimen__bio__month_of_shipment	12
biospecimen__bio__pathology_report_file_name	TCGA-G3-A7M7.9EC72408-F4C7-4D95-ACE3-3BF44E10FF8C.pdf
biospecimen__bio__plate_column	11
biospecimen__bio__plate_id	A358
biospecimen__bio__plate_row	F
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	2
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-G3-A7M7
biospecimen__shared__patient_id	A7M7
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	EA515450-E914-4924-A06E-1601CEA2879E
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.2
clinical__chol_lihc_shared__albumin_result_specified_value	3.5
clinical__chol_lihc_shared__albumin_result_upper_limit	4.6
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.5
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.2
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.6
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	7
clinical__chol_lihc_shared__fetoprotein_outcome_value	4
clinical__chol_lihc_shared__fibrosis_ishak_score	3,4 - Fibrous Speta
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	1.1
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	65
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-A7M7-F67243
clinical__clin_shared__bcr_followup_uuid	2394BC71-9ED7-43E0-84DD-BE17F84C0A77
clinical__clin_shared__day_of_form_completion	3
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	2
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	145
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Severe
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G1
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	80dfe1d4-43f2-4bd2-9578-4e1fa9056690
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-A7M7-01A-12R-A358-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	017f7fea-836e-488e-8e8d-82aa04e1a8fa
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.8
gdc__analytes__analyte_id	6f0ebd8a-548b-4a34-8739-9593fde46914
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	3d048a45-3d5d-4563-acc8-3c662861f18a
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:34:57.516354-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	c5af7d07-b7b7-5959-b58c-802a81477c2a
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1948
gdc__diagnoses__age_at_diagnosis	24002
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-24002.0
gdc__diagnoses__days_to_last_follow_up	361.0
gdc__diagnoses__diagnosis_id	5b5f92ec-f125-525c-87d5-3aa01b397857
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	23.503556057507403
gdc__exposures__exposure_id	89eda314-1edf-5819-bccf-40d0c98b0ffa
gdc__exposures__height	181.0
gdc__exposures__weight	77.0
gdc__file_id	cabad780-503a-4c7c-a3a1-db9ed6e2957e
gdc__file_name	ed7def30-5c70-4235-a8b1-0d780fd9db93.mirbase21.mirnas.quantification.txt
gdc__file_size	50211
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	8548f40a52d2a970ec727d65f790f919
gdc__portions__is_ffpe	false
gdc__portions__portion_id	a016824d-4875-4f78-b2db-50e29c0bd0de
gdc__portions__portion_number	01
gdc__portions__weight	40.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	112
gdc__samples__initial_weight	750.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	9EC72408-F4C7-4D95-ACE3-3BF44E10FF8C
gdc__samples__sample_id	fd7c8159-102b-4af5-ae93-4e468e54ec10
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	5.0
gdc__slides__percent_neutrophil_infiltration	2.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	25.0
gdc__slides__percent_tumor_cells	70.0
gdc__slides__percent_tumor_nuclei	70.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	6d6486e1-75bf-47b3-8394-280ad3b2d536
gdc__submitter_id	mirna_swap_dr11_193_MirnaExpressionfd48d419-5318-4d61-8bb9-98925a38cee9_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	f5104981-d9b0-559c-bc4a-5fede4a515dd
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:41.588+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/80dfe1d4-43f2-4bd2-9578-4e1fa9056690-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/80dfe1d4-43f2-4bd2-9578-4e1fa9056690-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129582
manually_curated__local_md5	d4c868af64ae37c544747a77ab1f48cb
manually_curated__opengdc_download_date	2018-10-16T17:10:34.000402+02:00
manually_curated__opengdc_file_md5	0e24fd200278353e469dbc2feffd9a12
manually_curated__opengdc_file_size	50210
manually_curated__opengdc_id	80dfe1d4-43f2-4bd2-9578-4e1fa9056690-meq
manually_curated__origin_file_size	129582
manually_curated__origin_last_modified_date	Tue Oct 16 17:27:00 CEST 2018
manually_curated__origin_md5	d4c868af64ae37c544747a77ab1f48cb
manually_curated__tissue_status	tumoral
